Steroid free remission! Or is it? This week I discuss a really exciting trial in ANCA vasculitis.
E72: Avacopan for ANCA Vasculitis
February 25th, 2021
E71: MTX Discontinuation Post… Influenza Vaccination
January 27th, 2021
I stole some time to tackle a pressing issue for rheumatologists - to hold or not to hold immunosuppression in patients who are receiving a COVID19 vaccination. We obviously don't have any data on this, but I have always loved this study on influenza vaccination. PDFs at ebrheum.com/twts and follow me on twitter @ebrheum!
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
November 19th, 2020
We have a great show for you this week! Anisha Dua will be moderating a debate
between myself and Max Konig on this motion: "Hydroxychloroquine levels should be monitored in patients with SLE." I learned a ton and thoroughly enjoyed it. Be sure to vote on the post-debate twitter poll to decide the winner!
E69: Publication Trends in SRMAs and RCTs
October 29th, 2020
This week I cover another of my meta-research projects, this one on systematic review and meta analysis (SRMA) growth as compared to randomized clinical trial (RCT) growth. Short and to the point - hope you enjoy! I highly recommend checking out the associated graphs - just take a quick peek at some point while listening. Find them on my twitter handle @ebrheum
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
October 15th, 2020
Active comparator trial! Always my favorite. Lots of fun topics in this one, including noninferiority trials, crafty endpoints, and PROs. Check it out and let me know what you think! @ebrheum
E67: Belimumab in Lupus Nephritis (BLISS-LN)
October 1st, 2020
Another day, another lupus trial, another round of endpoint shenanigans. Why does that matter? How big is the benefit from belimumab in SLE nephritis? Will this save lives and prevent ESRD / RRT? I try to tackle these issues this week and (hopefully) avoid getting myself in trouble. Hope you enjoy the episode! Let me know what you think @ebrheum on twitter!
E66: MRI to Diagnose PMR
September 10th, 2020
Great paper to discuss this week - one that may be too good to believe? I highly recommend checking out the pdf first (ebrheum.com/twts) - their graphics are wonderful and do a great job of conveying their message. Also, check out the "2-5-10" rule that I referenced! This is required reading for anyone who rotates with me - easily one of the most useful EBM papers I have ever read.
E65: Anifrolumab in SLE - A Reply
September 2nd, 2020
Quick podcast this week that expands on issues I discuss in Episode 55. Go back and listen to that one first if you have time! I think this is an important issue and it's one I'd like to highlight. Let me know what you think @ebrheum and please share with friends!
E64: Antirheumatic Disease Therapies: A Systematic Review and Meta Analysis
August 27th, 2020
This week I wanted to share a recent systematic review and meta analysis, which was published by myself and a group on behalf of the Global Rheumatology Alliance. I use this as an opportunity to close out a few issues and describe the current landscape. After this I'm planning to go back to good old rheumatology-based podcasts for a few months!
E63: Housekeeping #3
August 27th, 2020
The podcast is back! I tune in briefly here to explain where I've been, what I'm doing, and where this will be headed. Feel free to skip right ahead if you'd rather just dig back in!